Richard Kitzmiller takes orders for the cars from customers all over the world and is one of only a few custom builders of vintage race cars. There are some shops making Cobras, he said, but Scarabs are harder to come by because their production was so limited in the first place.
Gladstone’s B&B Theatres is renovating its Westglen theater, putting in new electric reclining seats, a new snack bar, new parking lot and more. Tom Tivol, with more than four decades in the jewelry business, is opening a location in Leawood’s Park Place. Alysa Rene Boutique is relocating and expanding in Park Place.
Apple will have to pay up to 13 billion euros ($14.5 billion) plus interest in back taxes to Ireland after the European Union found Tuesday that the U.S. technology giant had paid next to no tax across the bloc's 28 countries for over 11 years.
The maker of EpiPens will start selling a cheaper, generic version of the emergency allergy shots as the furor over repeated U.S. price hikes continues — and looming competition threatens its near-monopoly.
Kansas City-based MRIGlobal and the University of Missouri will investigate the Zika virus infection and how it is transmitted, particularly from mothers to babies. The grant was awarded by the Kansas City Area Life Sciences Institute.
There will be 600,000 commercial drone aircraft operating in the U.S. within the year as the result of new safety rules that opened the skies to them on Monday, according to a Federal Aviation Administration estimate.
Southwest Airlines Co. and its pilots union agreed on the basics of a contract that would provide an immediate 15 percent pay raise followed by four annual increases of 3 percent, plus a ratification bonus.
A former Arkansas state representative has filed a lawsuit against a House candidate, saying he's disqualified from serving in the Legislature due to a misdemeanor conviction for writing a bounced check.
In a White House Press Briefing on Thursday, White House Press Secretary Josh Earnest said some pharmaceutical companies have been innovators committed to advancing public health, and others have jacked up the prices of life-saving medicine — a poor business model, which takes a toll on the business' reputation and stock prices.